MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) today welcomed the U.S. Food and Drug Administration’s (FDA) newly released draft guidance on the development of ...
MATAWAN, N.J. & LA JOLLA, Calif., February 11, 2026--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) ...
InscoBio, a KOSPI-listed company (CEO Gu Ja-gap), announced on the 26th that it has completed the first phase of capital expansion through equity conversion and a paid-in capital increase of its U.S.
Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) Division of Anesthesiology, Addiction Medicine and Pain Medicine (DAAP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results